Literature DB >> 31982397

The need for rapid therapeutic efficacy testing for cancer therapy.

David G Kaufman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31982397      PMCID: PMC9261964          DOI: 10.1016/j.yexmp.2020.104382

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   4.401


× No keyword cloud information.
  44 in total

1.  Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris.

Authors:  Theodor Boveri
Journal:  J Cell Sci       Date:  2008-01       Impact factor: 5.285

Review 2.  DNA methylation errors and cancer.

Authors:  P A Jones
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma.

Authors:  A G Knudson; H W Hethcote; B W Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

Review 4.  Precision medicine for cancer with next-generation functional diagnostics.

Authors:  Adam A Friedman; Anthony Letai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Cancer       Date:  2015-11-05       Impact factor: 60.716

5.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

Review 6.  Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone.

Authors:  Edgardo Rivera; Henry Gomez
Journal:  Breast Cancer Res       Date:  2010-10-22       Impact factor: 6.466

7.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

8.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.

Authors:  Gillian L Dalgliesh; Kyle Furge; Chris Greenman; Lina Chen; Graham Bignell; Adam Butler; Helen Davies; Sarah Edkins; Claire Hardy; Calli Latimer; Jon Teague; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J Campbell; Simon Forbes; Mingming Jia; David Jones; Henry Knott; Chai Yin Kok; King Wai Lau; Catherine Leroy; Meng-Lay Lin; David J McBride; Mark Maddison; Simon Maguire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Sarah O'Meara; Erin Pleasance; Arjunan Rajasingham; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick S Tarpey; Kelly Turrell; Karl J Dykema; Sok Kean Khoo; David Petillo; Bill Wondergem; John Anema; Richard J Kahnoski; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962

9.  A two-stage theory of carcinogenesis in relation to the age distribution of human cancer.

Authors:  P ARMITAGE; R DOLL
Journal:  Br J Cancer       Date:  1957-06       Impact factor: 7.640

Review 10.  Drug resistance in cancer: an overview.

Authors:  Genevieve Housman; Shannon Byler; Sarah Heerboth; Karolina Lapinska; Mckenna Longacre; Nicole Snyder; Sibaji Sarkar
Journal:  Cancers (Basel)       Date:  2014-09-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.